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Abstract 
The aim of this paper is to propose equations for the diffusion of drugs for investigated
drug/hydrogel systems using the parameters affecting the transport of drug through poly-
(2-hydroxyethylmethacrylate/itaconic acid) (P(HEMA/IA)), poly(2-hydroxyethylacrylate/ita-
conic acid) (P(HEA/IA)), and poly(2-hydroxyethylmethacrylate/poly(alkyleneglycol) (meth)-
acrylates) (P(HEMA/BIS)) copolymeric hydrogels. Different monomer types, as well as the 
variable content of some components in hydrogel composition (the amount of ionizable
comonomer (IA) and different type of nonionic poly(alkyleneglycol) (meth)acrylates), ulti-
mately defined the pore size available for drug diffusion. The hydrogels synthesized ranged 
from nonporous to microporous, based on the classification in accordance to the pore size,
and could be classified as hydrogels that contain ionic groups and hydrogels without ionic
groups. The drugs selected for this study are bronchodilators-theophylline (TPH), fene-
thylline hydrochloride (FE), and antibiotic cephalexin (CEX). Results of in vitro drug release 
tests defined the release systems based on the drug type, as well as the type of hydrogel
used. The diffusion coefficient of drugs and the restriction coefficient, λ, defined as the 
ratio of solute to “pore” radius (rs/rζ) that describes the ease of drug release from the gels,
were used as factors that govern the release process. 
Keywords: hydrogels; 2-hydroxyethyl methacrylate; 2-hydroxyethyl acrylate; poly(alkylene 
glycol) (meth)acrylates; itaconic acid; controlled drug release; controlled drug release pa-
rameters; diffusion equations. 
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Hydrogels are hydrophilic, crosslinked polymers 
made of homo- or copolymers that can absorb signi-
ficant amounts of water or biological fluids but do not 
dissolve owing to the presence of chemical or physical 
crosslinks [1–3]. Their hydrophilic surface is character-
ized by a low interfacial free energy in contact with 
body fluids, which results in a low tendency for pro-
teins and cells to adhere to these surfaces.
 Hydrogels 
resemble natural living tissue more than any other class 
of synthetic biomaterials. This is due to their high water 
contents and soft consistency, which is similar to natu-
ral tissue. Furthermore, the high water content of the 
materials contributes to their biocompatibility. There-
fore hydrogels have found widespread biomedical and 
pharmaceutical applications as medical devices (con-
tact lenses, artificial hearts and skin), and as controlled 
drug delivery systems [4–8].  
Special types of hydrogels known as stimuli-res-
ponsive have been investigated for the development of 
“smart” materials in various fields. The term “stimuli-
responsive” implies that significant changes of key pro-
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perties can be induced by an external stimulus, such as 
pH value, temperature, ionic strength, pressure, light, 
or electrical and magnetic fields [5]. 
Due to their excellent characteristics poly(2-hydro-
xyethylmethacrylate) (PHEMA), poly(2-hydroxyethylac-
rylate) (PHEA), itaconic acid (IA) and poly(alkylene-
glycol) (meth)acrylates (BIS) are favorable as compo-
nents of “smart” materials. PHEMA has excellent bio-
compatibility and physicochemical properties similar to 
those of living tissues [9,10]. PHEA has similar biocom-
patibility, cytotoxicity, low thrombogenicity, and cell 
compatibility to the widely studied PHEMA, but it is a 
less frequently studied polymer. Compared to PHEMA, 
PHEA seems to be a better option for the case of simu-
lating the mechanical properties of soft tissues without 
losing water sorption capacity [11]. Itaconic acid (IA) 
easily copolymerizes and provides polymer chains with 
carboxylic side groups, which are highly hydrophilic and 
able to form hydrogen bonds with corresponding 
groups or ionize at adequate pH values. The addition of 
very small amounts of IA to HEMA and HEA hydrogels 
renders good pH sensitivity and increases the degree of 
hydrogel swelling [12–16]. Furthermore, IA is expected 
to show high biocompatibility because of its natural 
source [17]. Due to good biocompatibility and safe to-
xicity profile, poly(ethylene glycol)s (PEGs) are applied M.M. BABIĆ et al.: DIFFUSION OF DRUGS IN HYDROGELS BASED ON (METH)ACRYLATES  Hem. ind. 66 (6) 823–829 (2012) 
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in various biomedical areas such as drug delivery, 
wound healing, and tissue repair systems [18–21].  
Poly(2-hydroxyethylmethacrylate/itaconic acid) 
(P(HEMA/IA)), poly(2-hydroxyethylacrylate/itaconic 
acid) (P(HEA/IA)), and poly(2-hydroxyethylmethacry-
late)/poly(alkyleneglycol) (meth)acrylates (P(HEMA/BIS)) 
copolymeric hydrogels, which were characterized in 
our earlier papers [12–16], showed significant potential 
for application in drug delivery systems. The drug re-
lease studies were carried out in vitro, using broncho-
dilators-theophylline (TPH) and fenethylline hydro-
chloride (FE), and antibiotic cephalexin (CEX). In order 
to give deeper insight into controlled release of used 
drugs from these hydrogels, as a function of gel struc-
ture and morphology, its water sorption capabilities 
and the drug type, model equations describing solute 
diffusion through these hydrogels have been proposed 
for each drug/hydrogel system. 
EXPERIMENTAL 
Materials 
2-Hydroxyethyl methacrylate (HEMA) (Aldrich), 2- 
-hydroxyethyl acrylate (HEA) (Aldrich), itaconic acid (IA) 
(Fluka), and different poly(alkylene glycol) (meth)acryl-
ates (BIS) (BIS1-poly(ethylene glycol)5 monoacrylate, 
BIS2-poly(propylene glycol)6 monomethacrylate, BIS3- 
-poly(ethylene glycol)6(propylene glycol)3 monometha-
crylate, and BIS4-poly(ethylene glycol)3(propylene gly-
col)6 monomethacrylate) (Laporte Chemicals) were 
used as components for hydrogel preparation. All poly-
merizations were performed in a mixture of water/ 
/ethanol as solvent. Ethyleneglycol dimethacrylate 
(EGDMA, Aldrich) was used as crosslinking agent and 
potassium persulfate (KPS, Fluka) and N,N,N’,N’–tetra-
methylethylene diamine (TEMED, Aldrich) as initiator 
and activator, respectively. Theophylline (TPH) (Sigma), 
fenethylline hydrochloride (FE) (Sigma) and cephalexin 
(CEX) (Sigma) were used as drugs (Figure 1). Buffer 
solution was prepared using potassium mono and di-
hydrogenphosphate (Fluka) and sodium hydroxide 
(Fluka). Demineralized water was used for all poly-
merizations and the preparation of the buffer solutions. 
Preparation of hydrogels 
The P(HEMA/IA) and P(HEMA/BIS) hydrogels were 
prepared by gamma radiation induced crosslinking/ 
/polimerization. The reaction solutions were irradiated 
in a 
60Co radiation source, under ambient conditions, at 
a dose rate of 0.5 kGy/h, to an absorbed dose of 25 
kGy. The P(HEA/IA) hydrogels were prepared by free 
radical crosslinking/copolymerization. The initiator, ac-
tivator and crosslinker were added to the monomer 
feed mixture dissolved in water/ethanol mixture. The 
reaction mixture was degassed prior to polymerization 
and placed between two glass plates sealed with a rub-
ber spacer (2 mm thick). The polymerizations were car-
ried out at 50 °C for 24 h. After the reaction, the gels 
were cut into discs and immersed in water for a week, 
to remove unreacted components. The water was 
changed daily. The discs were dried to xerogels. 
The amount of uncrosslinked IA was determined by 
titration of extract against NaOH (0.05 mol/l) to phe-
nolphthalein end point. On the other hand, the amount 
of uncrosslinked HEMA and BIS were determined using 
a UV spectroscopy. In all cases, the results indicate that 
the conversion during cross-linking reaction was nearly 
complete. 
 
Figure 1. Chemical structures of used drugs – theophylline (TPH), fenethylline hydrochloride (FE), and cephalexin (CEX). M.M. BABIĆ et al.: DIFFUSION OF DRUGS IN HYDROGELS BASED ON (METH)ACRYLATES  Hem. ind. 66 (6) 823–829 (2012) 
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Drug release study 
The drug powder (about 5% of the xerogel weight) 
was dissolved in water. All xerogel discs were im-
mersed in drug solution and swollen to equilibrium. 
The swollen drug-loaded samples were then dried at 
ambient temperature for several days to constant mass 
and used for the release experiments. Release studies 
have been carried out in vitro by placing the dried and 
loaded sample in a definite volume of the release me-
dium (a buffer of pH 7.40 (simulated physiological 
fluid)) at 37 °C. The amount of drug released was mea-
sured using a UV spectrophotometer (Shimadzu UV–Vis 
spectrophotometer UV-1800), by taking the absorb-
ance of the solution at regular time intervals, at a wa-
velength of 272, 274, and 262 nm for TPH, FE and CEX, 
respectively. These measurements were repeated in 
triplicate. The concentration of the drug in the external 
solution at any selected time, ct, was calculated from 
the corresponding calibration curve of the absorbance 
against drug concentration. The data were analysed 
using the commercial Origin Microcal 8.0 software.  
RESULTS AND DISCUSSION 
Diffusion properties of drug/hydrogel systems 
The release of drug molecules from hydrogels de-
pends on the characteristics of the network: the po-
lymer chemical structure and the network morphology. 
On the other hand, the physicochemical properties of 
the drugs also influence the release behavior.  
Drug transport in hydrogels can be analyzed using 
the frictional characteristics of the spherical solutes 
(drugs) as they diffuse through cylindrical pores. Deri-
vation of drug transport through pores is based on the 
equation of drug flux with additional hindrance terms 
for convection and restrictions due to the tortuosity of 
the transport path. The apparent diffusion coefficient 
for the drug diffusion in a gel, Dd(gel), relative to the 
diffusion coefficient of the solute in the liquid at infinite 
dilution, Dd(water), is related to the restriction coefficient, 
λ, defined as the ratio of drug radius to hydrogel pore 
size. The coefficient λ combines the influence of poly-
meric network structure and the size of the drug on 
release and transport properties. The diffusion coeffi-
cients for solute diffusion in a gel, Dd(gel), is calculated 
from Eq. (1), with the mass transfer principles based on 
Fick's law [22]:  
22
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where k is kinetic constant obtained from dynamic re-
lease studies (dependence ct/ce on t) and l is the thick-
ness of the gel. The hydrodynamic radius of the drug 
molecule, rd, was calculated assuming a spherical shape 
[23], from relation (2):  
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where NA is Avogadro’s number, V is the molar volume 
of the drug, calculated from the partial specific volume 
of the atomic contribution of Le Bas [24]. The cal-
culated values of the hydrodynamic radii are presented 
in Table 1. 
Table 1. Values of molecular weights, Md, hydrodynamic radii, 
rd, and bulk diffusion coefficients, Dd(water), of the drugs 
Drug  Md / g mol
–1  rd / nm  Dd(water)×10
6 / cm
2 s
–1
TPH 180.2  0.36  9.02 
FE 362.5  0.51  6.44 
CEX 347.4  0.51  6.44 
The drug diffusion coefficient in the liquid at infinite 
dilution Dd(water) was calculated for each drug employed 
in this investigation (Table 1), using the Stokes–Einstein 
Equation: 
(water) 6
d
d
kT
D
r πη
=  (3) 
where k is the Boltzmann constant, T is the absolute 
temperature,  η is the solvent viscosity and rd is the 
hydrodynamic radius of the drug. In general, a solute is 
considered to follow Stokes law if the solvent can be 
treated as a continuum (i.e., rdrug >> rsolvent). 
The mean pore size, ξ, of hydrogels was calculated 
from [25], using relation (4): 
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where φ2 is volume fraction of the swollen polymer, l is 
the carbon–carbon single bond length (0.154 nm), Cn is 
the rigidity factor of the polymer [15], Mc is the average 
molar mass between the crosslinks [15] and Mr is the 
molar mass of repeat unit. The calculated mean pore 
size ξ of the hydrogels (from aforementioned relation) 
ranged from 0.85 to 3.89 nm for P(HEMA/IA), 0.18– 
–2.21 nm for P(HEMA/BIS) (nonporous), and 1.45–24.9 
nm for P(HEA/IA) hydrogels (microporous).  
The diffusion coefficients of the drugs and drug 
release exponents, n, for P(HEMA/IA), P(HEMA/BIS), 
and P(HEA/IA) hydrogels, obtained from the results of 
drug release studies, are presented in Table 2. The va-
lues of drug release exponents n are near 0.5 in all 
cases (Table 2), suggesting that the release process can 
be described by a Fickian transport mechanism. M.M. BABIĆ et al.: DIFFUSION OF DRUGS IN HYDROGELS BASED ON (METH)ACRYLATES  Hem. ind. 66 (6) 823–829 (2012) 
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Table 2. Diffusion parameters of the investigated 
drug/hydrogel systems 
Drug Hydrogel  k  n  Dd(gel)×10
7 / cm
2 s
–1
TPH PHEMA  0.30  0.44  0.79 
P(HEMA/2IA) 0.31  0.45  0.88 
P(HEMA/3.5IA) 0.34  0.46  1.23 
P(HEMA/5IA) 0.50  0.52  1.55 
FE PHEMA  0.23  0.46  0.43 
P(HEMA/2IA) 0.24  0.49  0.55 
P(HEMA/3.5IA) 0.25  0.50  0.66 
P(HEMA/5IA) 0.33  0.50  0.94 
CEX P(HEMA/BIS1) 0.410  0.38  24.43 
P(HEMA/BIS2) 0.240  0.35  21.53 
P(HEMA/BIS3) 0.195  0.30  13.94 
P(HEMA/BIS4) 0.151  0.29  4.05 
PHEA 0.46  0.52  2.26 
P(HEA/2IA) 0.57 0.52  3.51 
P(HEA/3.5IA) 0.63 0.47  4.62 
P(HEA/5IA) 0.68 0.51  4.76 
Drug transport in hydrogels  
Among controlled release drug delivery systems, 
hydrogels are interesting due to their unique tunable 
time-dependent swelling behavior. The purpose of con-
trolled release systems is to deliver the drug at spe-
cified rate to a desired target, keeping the drug concen-
tration in the body at the therapeutically effective 
level, with the convenient drug release profile [24]. 
The structure of drugs: theophylline (TPH), fenethyl-
line hydrochloride (FE), and cephalexin (CEX), used for 
the investigation of the drug release behavior of hydro-
gels prepared in this study, are presented in Figure 1. 
The bronchodilatators theophylline (TPH) and fenethyl-
line hydrochloride (FE), loaded in P(HEMA/IA) hydro-
gels, contain –HN– functional groups and the antibiotic 
cephalexine (CEX) (pKa = 11.9), loaded in P(HEMA/BIS) 
and P(HEA/IA) hydrogels, contains –NH2 and –COOH 
functional groups which can interact effectively with 
hydrogel functional groups (COO
–, OH) through ionic or 
hydrogen bonds. Hydrogen bonds can be formed also 
between –OH groups from BIS components of P(HEMA/ 
/BIS) hydrogels and the functional groups of CEX. 
Therefore, drug release process in a buffer solution of 
pH 7.4, at 37 °C is influenced by the composition of 
hydrogel.  
The drug restriction coefficient λ describes the ease 
of drug release from the gels. As it can be seen from 
Figures 2 and 3, the solute transport, presented by 
normalized diffusion coefficient as a function of λ, is 
best correlated by exponential functions for the release 
of TPH, FE and CEX from P(HEMA/IA), P(HEA/IA) (Figure 
2) and P(HEMA/BIS) hydrogels (Figure 3).  
The equations which describe the diffusion of TPH 
and FE through P(HEMA/IA) hydrogels, and CEX diffu-
sion through P(HEMA/BIS) and P(HEA/IA) hydrogels are 
presented in Table 3.  
The gels investigated can be divided in two groups. 
In the first group are pH-sensitive networks, P(HEMA/ 
/IA) and P(HEA/IA), which contain ionic groups from IA, 
where hydrogen bonding, physical crosslinks, and elec-
trostatic and hydrophobic interactions can take place 
with the corresponding functional groups of the drug. 
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Figure 2. Normalized drug diffusion coefficient for TPH and FE release from P(HEMA/IA) hydrogels, and for CEX release from 
P(HEA/IA) hydrogels as a function of drug restriction coefficient.M.M. BABIĆ et al.: DIFFUSION OF DRUGS IN HYDROGELS BASED ON (METH)ACRYLATES  Hem. ind. 66 (6) 823–829 (2012) 
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In the second group are the nonionic P(HEMA/BIS) hyd-
rogels, which have no ionic groups so the electrostatic 
interactions between the gel and the drug do not take 
place. For the reason of easier comparison, drugs with 
similar dimensions were chosen. 
When the polymer network is pH-sensitive, the 
drug is entrained within a network so the drug release 
is a function of the expansion of the pH-sensitive 
network, which is regulated by the monomer ratio, the 
cross-linking density and the pH value of the swelling 
media. In our experiments, the drug release studies 
were performed in a buffer of pH 7.4, which is higher 
than both pKa values of IA, so practically all IA residues 
in the polymeric network are ionized. Since the mono-
mer ratio is varied in our copolymer samples it is evi-
dent that the drug release is faster for the gels with 
higher IA content. For the gel containing HEMA mono-
mer and ionic groups from IA, THP/P(HEMA/IA) and 
FE/P(HEMA/IA), the lowest values for normalized diffu-
sion coefficients were obtained. It is to be expected for 
two reasons: pores in these systems fall into the non-
porous region and interactions between the functional 
groups of the drugs and of the network chains are 
taking place. The system CEX/P(HEA/IA) has higher po-
res in the network (mesoporous region) due to more 
hydrophilic HEA residues, and the values for normalized 
diffusion coefficients are higher. In all cases presented 
in Figure 2, the normalized diffusion coefficients dec-
line exponentially with λ, but this trend is more pro-
nounced in the case of CEX/P(HEA/IA) system, with 
higher pores. 
In the case of P(HEMA/BIS) hydrogels, which are 
nonionic and have the smallest pores (nonporous re-
gion), much higher values of normalized diffusion coef-
ficients were obtained, but the same trend of expo-
nentially declining values with decreasing pore dimen-
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Figure 3. Normalized drug diffusion coefficient for CEX release from P(HEMA/BIS) hydrogels as a function of drug restriction 
coefficient. 
Table 3. Proposed diffusion equations for each drug/hydrogel system 
Drug Hydrogel  Equation 
TPH P(HEMA/IA) 
()
(gel) -3 -3
(water)
7.38 10 18.5 10 exp 6.66
d
d
D
D
λ =×+× −
FE P(HEMA/IA) 
()
(gel) -3 -3
(water)
5.97 10 17.2 10 exp 5.28
d
d
D
D
λ =×+× −
CEX P(HEA/IA) 
()
(gel) -2 -2
(water)
3.49 10 5.99 10 exp 27.62
d
d
D
D
λ =×+× −
CEX P(HEMA/BIS) 
()
(gel)
(water)
0.445 - 0.051exp 0.712
d
d
D
D
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sions is present. This behavior confirms that the diffu-
sion of drugs depend more on the interactions (most of 
all electrostatic) between the drug and network chains 
and less on the pore size.  
CONCLUSION 
Mathematical equations describing the diffusion of 
model drugs through drug delivery systems based on 2- 
-hydroxyethyl methacrylate (HEMA), and 2-hydroxy-
ethyl acrylate (HEA), different poly(alkylene glycol) 
(meth)acrylates (BIS) and itaconic acid (IA) were ob-
tained. Hydrogels were prepared by gamma-radiation 
induced crosslinking/polymerization, and chemically 
crosslinking/polymerization. Antibiotic cephalexin (CEX), 
and bronchodilatators theophylline (TPH) and fenethyl-
line hydrochloride (FE) were used as model drugs. The 
release of drugs from these hydrogels was investigated 
in vitro, in a buffer of pH 7.4, at 37 °C. The results of in 
vitro drug release studies showed that our release sys-
tems were determined by the type of drug, as well as 
by the type of hydrogel. The equations which describe 
the diffusion of TPH and FE through P(HEMA/IA) hyd-
rogels, and CEX diffusion through P(HEMA/BIS) and 
P(HEA/IA) hydrogels are given by the normalized diffu-
sion coefficient, Dd(gel))/(Dd(water), as a function of the 
restriction coefficient, λ. The dependence of norma-
lized diffusion coefficient on λ, are best correlated by 
exponential function in all cases. From the relations 
obtained it can be said that the diffusion of drugs, de-
pend more on the interactions (most of all electro-
static) between the drug and network chains and less 
on the pore size.  
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IZVOD 
DIFUZIJA LEKOVA U HIDROGELOVIMA NA BAZI (MET)AKRILATA, POLI(ALKILENGLIKOL)-(MET)AKRILATA I ITAKONSKE 
KISELINE 
Marija M. Babić
1, Jovana S. Jovašević
2, Jovanka M. Filipović
2, Simonida Lj. Tomić
2 
1Institut „Kirilo Savić“, Beograd, Srbija 
2Univerzitet u Beogradu, Tehnološko–metalurški fakultet, Beograd, Srbija 
(Naučni rad) 
Cilj ove studije je da se predlože difuzione jednačine za ispitivane sisteme 
lek/hidrogel. Korišćeni su hidrogelovi poli(2-hidroksietilmetakrilat/itakonska kise-
lina) (P(HEMA/IK)), poli(2-hidroksietilakrilat/itakonska kiselina) (P(HEA/IK)) i poli-
(2-hidroksietilmetakrilat/poli(alkilenglikol)-(met)akrilati) (P(HEMA/BIS)). Kompo-
nenta koja se menja u sastavu hidrogela HEMA, HEA, kao i udeo komponente sa
promenljivim sadržajem (udeo jonizujućeg komonomera (IK) i tip BIS kompo-
nente) definiše veličinu pora koja je dostupna za difuziju leka. U ovoj studiji su 
korišćeni lekovi bronhodilatori teofilin (TPH) i fenetilin-hidrohlorid (FE), i antibiotik
cefaleksin (CEX). Ovi gelovi su klasifikovani u režimu poroznosti kao neporozni i
mikroporozni, sa veličinom pora u opsegu 0,18–24,9 nm. Kontrolisano otpuštanje 
lekova je izvedeno u in vitro uslovima u puferu pH 7,40 i na 37 °C, da bi se odredili 
difuzioni koeficijenti leka u hidrogelovima. Na osnovu toga su predložene jedna-
čine difuzije leka kroz hidrogel za svaki sistem lek/hidrogel. Rezultati dobijeni fito-
vanjem eksperimentalnih podataka su pokazali da difuzija leka zavisi od hemijske
strukture i morfologije hidrogela i parametra λ, koji predstavlja odnos prečnika 
leka i veličine pora. Eksponencijalna zavisnost koeficijenta restrikcije od normali-
zovanog koeficijenta difuzije je dobijena za sisteme TPH/P(HEMA/IA), FE/P(HEMA/
/IA), CEX/P(HEMA/BIS) i CEX/P(HEA/IA) .Utvrđeno je da veliki uticaj na difuziju
leka imaju interakcije koje se odigravaju između funkcionalnih grupa leka i poli-
merne mreže. 
  Ključne reči: hidrogelovi • 2-hidroksietil-
metakrilat  • 2-Hidroksietilakrilat • Poli-
(alkilenglikol)-(met)akrilati  • Itakonska 
kiselina • Kontrolisano otpuštanje leka •
Parametri kontrolisanog otpuštanja leka
• Jednačine difuzije 
 